2015 American Transplant Congress » Concurrent Session: Kidney Antibody Mediated Rejection II

Date: Sunday, May 3, 2015

Time: 4:00pm-5:30pm

Location: Terrace I-III

Session Type: Concurrent Session

Meeting: 2015 American Transplant Congress

4:00pm-4:12pm: Microvascular Inflammation in Early Protocol Biopsies of Renal Allografts in Cases of Chronic Active Antibody-Mediated Rejection

T. Tsuji,¹ M. Yanai,¹ H. Itami,¹ Y. Ishii,¹ M. Akimoto,¹ N. Fukuzawa,² H. Harada,² Y. Fukasawa.¹

4:12pm-4:24pm: DSA MFI Does Not Predict Late Antibody-Mediated Rejection Lesions Or Gene Expression Changes in Kidney Transplants

L. Hidalgo,¹ J. Venner,² P. Halloran.²

4:24pm-4:36pm: De Novo DSA Would Not Necessarily Cause Graft Rejection After Renal Transplantation: Characteristics of DSA Developing Biopsy-Proven Chronic Antibody-Mediated Rejection

T. Yamamoto, Y. Watarai, A. Takeda, M. Okada, M. Tsujita, H. Takahisa, N. Goto, S. Narumi, T. Kobayashi.

4:36pm-4:48pm: Part II: Rates and Determinants of Progression for De Novo Donor-Specific Antibody Mediated Kidney Allograft Injury

C. Wiebe,^1,2 I. Gibson,³ D. Pochinco,² P. Birk,⁴ T. Blydt-Hansen,⁴ J. Ho,^1,5 M. Karpinski,¹ A. Goldberg,⁴ L. Storsley,¹ D. Rush,¹ P. Nickerson.^1,2,5

4:48pm-5:00pm: Impact of Donor Specific Antibodies in the Older Kidney Transplant Recipient

S. Patel, J. Loucks-DeVos, R. Knight, S. Kuten, L. Gaber, A. Gaber.

5:00pm-5:12pm: Long Term Outcomes of Tocilizumab Therapy for DSA+ Antibody Mediated Rejection (ABMR) Resistant to IVIG + Rituxan (I+R) Treatment

J. Choi,¹ A. Vo,¹ J. Kahwaji,¹ M. Haas,² N. Reinsmoen,³ D. Puliyanda,¹ A. Peng,¹ R. Villicana,¹ S. Jordan.¹

5:12pm-5:24pm: Late Antibody-Mediated Rejection in a Large Cross-Sectional Cohort of Kidney Transplant Recipients – Results of the Screening Phase of the BORTEJECT Study

F. Eskandary,¹ G. Bond,¹ H. Regele,² N. Kozakowski,² Z. Kikic,¹ M. Wahrmann,¹ H. Haslacher,³ R. Oberbauer,¹ V. Ramassar,⁴ P. Halloran,⁴ G. Böhmig.¹

« View all sessions from the 2015 American Transplant Congress